IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubinstein, I.
Right arrow Articles by Gao, X.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubinstein, I.
Right arrow Articles by Gao, X.-P.

 Previous Article  |  Next Article 

Infection and Immunity, February 2001, p. 1199-1201, Vol. 69, No. 2
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.2.1199-1201.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mechanisms Mediating Porphyromonas gingivalis Gingipain RgpA-Induced Oral Mucosa Inflammation In Vivo

Israel Rubinstein,1,2,* Jan Potempa,3 James Travis,4 and Xiao-Pei Gao1

Departments of Medicine1 and Pharmaceutics and Pharmacodynamics,2 University of Illinois at Chicago and VA Chicago Health Care System West Side Division, Chicago, Illinois 60612; Department of Microbiology, Institute of Molecular Biology, Tagiellonian University, Krakow, Poland3; and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 306024

Received 6 July 2000/Returned for modification 14 September 2000/Accepted 16 November 2000

Suffusion of gingipain RgpA (GRgpA) elicited a significant concentration-dependent increase in the clearance of macromolecules from in situ hamster cheek pouch which was attenuated by NPC 17647, a selective bradykinin B2 receptor antagonist. Leupeptin and a mixture of proteinase inhibitors also attenuated GRgpA-induced responses. These data indicate that GRgpA elicits plasma exudation from in situ oral mucosa in a catalytic site-dependent fashion by elaborating bradykinin.

* Corresponding author. Mailing address: Department of Medicine (M/C 787), University of Illinois at Chicago, 840 South Wood St., Chicago, IL 60612-7323. Phone: (312) 996-8039. Fax: (312) 996-4665. E-mail: IRubinst{at}uic.edu.

Infection and Immunity, February 2001, p. 1199-1201, Vol. 69, No. 2
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.2.1199-1201.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2001 by the American Society for Microbiology. All rights reserved.